Pharming Group N.V. ADS, each representing 10 ordinary shares

PHAR

...

PHAR: Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Show PHAR Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of PHAR by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by PHAR's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on PHAR's company Twitter account

WallStreetBets

Number of mentions of PHAR in WallStreetBets Daily Discussion

PHAR News

Recent insights relating to PHAR

CNBC Recommendations

Recent picks made for PHAR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PHAR

Corporate Flights

Flights by private jets registered to PHAR